2022 Speakers

Alan Watt

Chief Scientific Officer

NodThera

Bruno Reversade

Professor & Director

GIS, A*STAR, Singapore & KSHI, KAUST, Saudi Arabia

Niccolo Pengo

Chief Scientific Officer

Mabylon

Pablo Pelegrin

Scientific Deputy Director & Principal Investigator, BioMedical Research Institute of Murcia (IMIB-Arrixaca)

University of Murcia

Ashley Mansell

Head of Translational Sciences

Adiso Therapeutics

Hao Wu

Asa & Patricia Springer Professor

Boston Children’s Hospital & Harvard Medical School

Karen Cashmere

Chief Commercial Officer

ZyVersa

Tamara Seredenina

Group Leader TDP-43/Neuroinflammation

AC Immune

Bryan Oronsky

Chief Development Officer

EpicentRx

Juan Pablo de Rivero Vaccari

Associate Professor of Neurological Surgery & The Miami Project to Cure Paralysis

University of Miami Miller School of Medicine

Liang Shan

Assistant Professor

Washington University School of Medicine

Marc Pelletier

Senior Principal Scientist - Translational Immune Oncology

Novartis

Adam Keeney

Chief Executive Officer

NodThera

Anick Auger

Head of In Vitro & In Vivo Pharmacology

Ventus Therapeutics

Kate Fitzgerald

Professor & Vice Chair, Department of Medicine Division of Innate Immunity

University of Massachusetts Chan Medical School

Richard Gordon

Group Leader - Clinical Neuroscience

University of Queensland

Daniel Bachovchin

Assistant Member

Memorial Sloan Kettering Cancer Center

Kevin Wilhelmsen

Associate Director of Immunology

BIOAGE Labs

Luca Piali

Expert Scientist

Roche

Stephen Glover

Co-Founder, Chairman & Chief Executive Officer

ZyVersa

Anil Goyal

Chief Executive Officer & Board Director

IMMvention Therapeutix

David Bearss

Chief Executive Officer

Halia Therapeutics

Giulia D’Urso

Senior Scientist - Clinical

Roche

Jonathan Kagan

Marian R. Neutra, PhD Professor of Pediatrics

Harvard Medical School

Iain Fraser

Senior Investigator & Chief, Signaling Systems Section

National Institute of Allergy & Infectious Diseases, NIH

Kate Schroder

Affiliate Professor

University of Queensland

Robert Keane

Professor

University of Miami

Salvatore Alesci

Chief Scientific Officer

Invea Therapeutics

Aprile Pilon

Chief Executive Officer

Trove Therapeutics

Ariana Farrand

Associate Director, Translational Research

The Michael J. Fox Foundation for Parkinson’s Research

Bradlee Heckmann

Chief Scientific Officer & Asst. Professor

Asha Therapeutics & USF Health Neuroscience Institute

Christian Elabd

Vice President, Research & Development

Spring Discovery

Hal Hoffman

Professor of Pediatrics & Medicine & Chief of the Division of Allergy, Immunology and Rheumatology in the Department of Pediatrics

UC San Diego/Rady Children’s Hospital

Marianthi Papakosta

Associate Director NeuroInflammation/ Neurodegeneration

Takeda

Martha O’Brien

Senior Research Scientist

Promega

Theresa Pizarro

Louis Pillemer Endowed Professor of Experimental Pathology

Case Western Reserve University